[go: up one dir, main page]

AU2002300271A1 - Recombinant dimeric envelope vaccine against flaviviral infection - Google Patents

Recombinant dimeric envelope vaccine against flaviviral infection

Info

Publication number
AU2002300271A1
AU2002300271A1 AU2002300271A AU2002300271A AU2002300271A1 AU 2002300271 A1 AU2002300271 A1 AU 2002300271A1 AU 2002300271 A AU2002300271 A AU 2002300271A AU 2002300271 A AU2002300271 A AU 2002300271A AU 2002300271 A1 AU2002300271 A1 AU 2002300271A1
Authority
AU
Australia
Prior art keywords
vaccine against
recombinant dimeric
flaviviral infection
envelope vaccine
against flaviviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002300271A
Other versions
AU2002300271B8 (en
AU2002300271B2 (en
Inventor
Beth-Ann G. Coller
Kent E. Harada
John M. Ivy
Michael Mcdonnell
Iain D. Peters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hawaii Biotech Inc
Original Assignee
Hawaii Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU85905/98A external-priority patent/AU752191B2/en
Application filed by Hawaii Biotech Inc filed Critical Hawaii Biotech Inc
Publication of AU2002300271A1 publication Critical patent/AU2002300271A1/en
Assigned to HAWAII BIOTECH, INC. reassignment HAWAII BIOTECH, INC. Amend patent request/document other than specification (104) Assignors: HAWAII BIOTECHNOLOGY GROUP, INC.
Application granted granted Critical
Publication of AU2002300271B2 publication Critical patent/AU2002300271B2/en
Publication of AU2002300271B8 publication Critical patent/AU2002300271B8/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002300271A 1997-07-31 2002-07-25 Recombinant dimeric envelope vaccine against flaviviral infection Expired AU2002300271B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/904227 1997-07-31
AU85905/98A AU752191B2 (en) 1997-07-31 1998-07-27 Recombinant dimeric envelope vaccine against flaviviral infection
PCT/US1998/015447 WO1999006068A2 (en) 1997-07-31 1998-07-27 Recombinant dimeric envelope vaccine against flaviviral infection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU85905/98A Division AU752191B2 (en) 1997-07-31 1998-07-27 Recombinant dimeric envelope vaccine against flaviviral infection

Publications (3)

Publication Number Publication Date
AU2002300271A1 true AU2002300271A1 (en) 2002-12-19
AU2002300271B2 AU2002300271B2 (en) 2006-02-02
AU2002300271B8 AU2002300271B8 (en) 2006-08-10

Family

ID=39301691

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300271A Expired AU2002300271B8 (en) 1997-07-31 2002-07-25 Recombinant dimeric envelope vaccine against flaviviral infection

Country Status (1)

Country Link
AU (1) AU2002300271B8 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0836482B1 (en) * 1995-05-24 2002-11-13 Hawaii Biotechnology Group, Inc. Subunit vaccine against flavivirus infection

Similar Documents

Publication Publication Date Title
AU6086300A (en) Recombinant envelope vaccine against flavivirus infection
AU3834999A (en) Recombinant venezuelan equine encephalitis virus vaccine
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
ZA975889B (en) HIV envelope polypeptides and vaccine.
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
AU6065998A (en) Influenza vaccine
AU9623898A (en) Vaccines
LU91326I2 (en) Human papillomavirus vaccine Ä6,11,16,18Ü (recombinant, adsorbed)
AU2277497A (en) Porcine reproductive and respiratory syndrome vaccine
AU5320296A (en) Modified viral envelope polypeptide
HK1046911A1 (en) Stabilized viral envelope proteins and uses thereof
AU6715094A (en) Recombinant vaccine
AU3552797A (en) Vaccine preparations
AU5118199A (en) Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine
AU2002300271A1 (en) Recombinant dimeric envelope vaccine against flaviviral infection
AU2638695A (en) Recombinant leukotriene-c4 synthase
AU2232399A (en) Recombinant ctb-based vaccines
AU4486997A (en) Buffer double air cushion
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
AU2003204722A1 (en) Recombinant nonstructural protein subunit vaccine against flaviviral infection
AU6075498A (en) Vaccines
AU7583998A (en) Human chemokine zchemo-8
AU8877998A (en) Oral vaccine
AU9786398A (en) Human dnax interleukin-40 (dil-40)
GB9702990D0 (en) Virus vaccine